Differentiation of Human Embryonic Stem Cells to Dopaminergic Neurons in Serum‐Free Suspension Culture

The use of human embryonic stem cells (hESCs) as a source of dopaminergic neurons for Parkinson's disease cell therapy will require the development of simple and reliable cell differentiation protocols. The use of cell cocultures, added extracellular signaling factors, or transgenic approaches to drive hESC differentiation could lead to additional regulatory as well as cell production delays for these therapies. Because the neuronal cell lineage seems to require limited or no signaling for its formation, we tested the ability of hESCs to differentiate to form dopamine‐producing neurons in a simple serum‐free suspension culture system. BG01 and BG03 hESCs were differentiated as suspension aggregates, and neural progenitors and neurons were detecz after 2–4 weeks. Plated neurons responded appropriately to electrophysiological cues. This differentiation was inhibited by early exposure to bone morphogenic protein (BMP)‐4, but a pulse of BMP‐4 from days 5 to 9 caused induction of peripheral neuronal differentiation. Real‐time polymerase chain reaction and whole‐mount immunocytochemistry demonstrated the expression of multiple markers of the midbrain dopaminergic phenotype in serum‐free differentiations. Neurons expressing tyrosine hydroxylase (TH) were killed by 6‐hydroxydopamine (6‐OHDA), a neurotoxic catecholamine. Upon plating, these cells released dopamine and other catecholamines in response to K+ depolarization. Surviving TH+ neurons, derived from the cells differentiated in serum‐free suspension cultures, were detected 8 weeks after transplantation into 6‐OHDA–lesioned rat brains. This work suggests that hESCs can differentiate in simple serum‐free suspension cultures to produce the large number of cells required for transplantation studies.

[1]  Y. Sasai,et al.  Ectodermal patterning in vertebrate embryos. , 1997, Developmental biology.

[2]  Ali H. Brivanlou,et al.  Neural induction, the default model and embryonic stem cells , 2002, Nature Reviews Neuroscience.

[3]  M. Rao,et al.  Microarray analysis of selected genes in neural stem and progenitor cells , 2002, Journal of neurochemistry.

[4]  K. Mizuseki,et al.  Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity , 2000, Neuron.

[5]  Vesna Sossi,et al.  A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease , 2003, Annals of neurology.

[6]  R. Neve,et al.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. , 1986, Brain research.

[7]  J. Itskovitz‐Eldor,et al.  Human Feeder Layers for Human Embryonic Stem Cells1 , 2003, Biology of reproduction.

[8]  Albert Francis Blakeslee,et al.  Department of Genetics , 1941 .

[9]  B J Hoffer,et al.  Dopamine neuron agenesis in Nurr1-deficient mice. , 1997, Science.

[10]  C. Freed.  Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Linzhao Cheng,et al.  Human Adult Marrow Cells Support Prolonged Expansion of Human Embryonic Stem Cells in Culture , 2003, Stem cells.

[12]  B. Novitch,et al.  Vertebrate neurogenesis is counteracted by Sox1–3 activity , 2003, Nature Neuroscience.

[13]  M. Beal,et al.  Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice , 2003, Nature Biotechnology.

[14]  M. Rao,et al.  Enrichment of Neurons and Neural Precursors from Human Embryonic Stem Cells , 2001, Experimental Neurology.

[15]  A. Brivanlou,et al.  Molecular signature of human embryonic stem cells and its comparison with the mouse. , 2003, Developmental biology.

[16]  R. McKay,et al.  Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease , 2002, Nature.

[17]  R. Puri,et al.  Gene expression in human embryonic stem cell lines: unique molecular signature. , 2004, Blood.

[18]  Nadine Kabbani,et al.  Enhanced Proliferation, Survival, and Dopaminergic Differentiation of CNS Precursors in Lowered Oxygen , 2000, The Journal of Neuroscience.

[19]  Kwang-Soo Kim,et al.  Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice. , 2003, Brain research. Molecular brain research.

[20]  R. McKay,et al.  Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats , 1998, Nature Biotechnology.

[21]  R. Darnell,et al.  A Hierarchy of Hu RNA Binding Proteins in Developing and Adult Neurons , 1997, The Journal of Neuroscience.

[22]  P. Mcgeer,et al.  Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K , 1990, Brain Research.

[23]  Wade K. Smith,et al.  Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization , 1989, Annals of neurology.

[24]  S. Roffler-Tarlov,et al.  Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. , 1998, Developmental biology.

[25]  O. Isacson,et al.  Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells , 2003, Annals of neurology.

[26]  T. Schulz,et al.  Directed neuronal differentiation of human embryonic stem cells , 2003, BMC Neuroscience.

[27]  A. Trounson,et al.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro , 2000, Nature Biotechnology.

[28]  Benjamin E. Reubinoff,et al.  Neural progenitors from human embryonic stem cells , 2001, Nature Biotechnology.

[29]  D. Price,et al.  Regulation of peripherin and neurofilament expression in regenerating rat motor neurons , 1990, Brain Research.

[30]  M. Smidt,et al.  Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Marius Wernig,et al.  In vitro differentiation of transplantable neural precursors from human embryonic stem cells , 2001, Nature Biotechnology.

[32]  Kenji Mizuseki,et al.  Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. Gibb,et al.  Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease , 1992, Brain Research.

[34]  C. Olanow,et al.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.

[35]  Chad A. Cowan,et al.  Derivation of embryonic stem-cell lines from human blastocysts. , 2004, The New England journal of medicine.

[36]  N. Lambert,et al.  Differentiation of rhesus embryonic stem cells to neural progenitors and neurons. , 2003, Biochemical and biophysical research communications.

[37]  Jos Prickaerts,et al.  Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway , 2002, Experimental Neurology.

[38]  J. Itskovitz‐Eldor,et al.  Differences between human and mouse embryonic stem cells. , 2004, Developmental biology.

[39]  J. Crook,et al.  Karyotype of human ES cells during extended culture , 2004, Nature Biotechnology.

[40]  P. Rathjen,et al.  Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. , 1999, Journal of cell science.

[41]  T. Schulz,et al.  Human Embryonic Stem Cell Lines Derived from Discarded Embryos , 2003, Stem cells.

[42]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[43]  Ahmet Hoke,et al.  Designing, Testing, and Validating a Focused Stem Cell Microarray for Characterization of Neural Stem Cells and Progenitor Cells , 2003, Stem cells.

[44]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[45]  R. McKay,et al.  Reply to “Survival of expanded dopaminergic precursors is critical for clinical trials” , 1998, Nature Neuroscience.

[46]  P. Sanberg,et al.  Neural transplantation for treatment of Parkinson's disease. , 2002, Drug discovery today.

[47]  R. Puri,et al.  Properties of Pluripotent Human Embryonic Stem Cells BG01 and BG02 , 2004, Stem cells.

[48]  Wolfgang Wurst,et al.  Fate of Midbrain Dopaminergic Neurons Controlled by the Engrailed Genes , 2001, The Journal of Neuroscience.

[49]  A. Knecht,et al.  Induction of the neural crest: a multigene process , 2002, Nature Reviews Genetics.

[50]  M. Palkovits,et al.  Dopamine Biosynthesis Is Selectively Abolished in Substantia Nigra/Ventral Tegmental Area but Not in Hypothalamic Neurons in Mice with Targeted Disruption of the Nurr1 Gene , 1998, Molecular and Cellular Neuroscience.

[51]  Takumi Miura,et al.  Properties of four human embryonic stem cell lines maintained in a feeder‐free culture system , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[52]  R. McKay,et al.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells , 2000, Nature Biotechnology.

[53]  Bruce G. Jenkins,et al.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Takumi Miura,et al.  Long‐term culture of human embryonic stem cells in feeder‐free conditions , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[55]  A. Sadikot,et al.  Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons , 2003, Development.

[56]  Anthony C. Willis,et al.  Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors , 1991, Cell.

[57]  P. Rathjen,et al.  Directed differentiation of pluripotent cells to neural lineages: homogeneous formation and differentiation of a neurectoderm population. , 2002, Development.

[58]  M. Richards,et al.  Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells , 2002, Nature Biotechnology.

[59]  C. Freed,et al.  Generation of Tyrosine Hydroxylase Positive Neurons from Human Embryonic Stem Cells after Coculture with Cellular Substrates and Exposure to GDNF , 2004, Stem cells.

[60]  J. E. Huettner,et al.  BMP-4 inhibits neural differentiation of murine embryonic stem cells. , 1999, Journal of neurobiology.

[61]  Robert E. Burke,et al.  Pitx3 is required for development of substantia nigra dopaminergic neurons , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  R. Lovell-Badge,et al.  A role for SOX1 in neural determination. , 1998, Development.

[63]  G. Horgan,et al.  Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .

[64]  M. Wiles,et al.  Embryonic stem cell development in a chemically defined medium. , 1999, Experimental cell research.

[65]  J. Haycock,et al.  Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity. , 1999, Molecular pharmacology.

[66]  W. Freed,et al.  Dopaminergic Differentiation of Human Embryonic Stem Cells , 2004, Stem cells.

[67]  Marten P. Smidt,et al.  A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b , 2000, Nature Neuroscience.

[68]  V. Tabar,et al.  Derivation of midbrain dopamine neurons from human embryonic stem cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  T. Jessell.  Neuronal specification in the spinal cord: inductive signals and transcriptional codes , 2000, Nature Reviews Genetics.

[70]  R. McKay,et al.  Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats , 1998, Nature Neuroscience.

[71]  K. Mizuseki,et al.  Generation of neural crest-derived peripheral neurons and floor plate cells from mouse and primate embryonic stem cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Smidt,et al.  CNS Expression Pattern of Lmx1b and Coexpression with Ptx Genes Suggest Functional Cooperativity in the Development of Forebrain Motor Control Systems , 2002, Molecular and Cellular Neuroscience.